Paper40423909
Cell-based artificial platelet production: historical milestones, emerging trends, and future directions.
Kim KM and 8 others. Blood Res, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Cell-based artificial platelet production: historical milestones, emerging trends, and future directions. Papers, record 40423909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40423909
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-based artificial platelet production: historical milestones, emerging trends, and future directions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants15
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| RS-2023-KH140972, HX23C1706 | Korean Cell-Based Artificial Blood Project funded by the Korean government (The Ministry of Science and ICT, The Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety | PubMed | ||
| NRF-2022R1C1C1011518 | National Research Foundation | PubMed | ||
| NRF-2022R1C1C1011518 | National Research Foundation | PubMed | ||
| NRF-2022R1C1C1011518 | National Research Foundation | PubMed | ||
| NRF-2022R1I1A2070940 | National Research Foundation | PubMed | ||
| NRF-2022R1C1C1011518 | National Research Foundation | PubMed | ||
| RS-2023-00236157 | Bio&Medical Technology Development Program of the NRF funded by the Korean government (MSIT) | PubMed | ||
| RS-2023-00236157 | Bio&Medical Technology Development Program of the NRF funded by the Korean government (MSIT) | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37294031 | Current status of platelet manufacturing in 3D or bioreactors. | Biotechnol Prog | 2023 | https://conductscience.org/library/papers/37294031 | PubMed |
| 2 | 25606631 | Platelet bioreactor-on-a-chip. | Blood | 2014 | https://conductscience.org/library/papers/25606631 | PubMed |
| 3 | 20412529 | Generation of HLA-deficient platelets from hematopoietic progenitor cells. | Transfusion | 2010 | https://conductscience.org/library/papers/20412529 | PubMed |
| 4 | 30487128 | Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line. | Blood | 2019 | https://conductscience.org/library/papers/30487128 | PubMed |
| 5 | 23618622 | Two differential flows in a bioreactor promoted platelet generation from human pluripotent stem cell-derived megakaryocytes. | Exp Hematol | 2013 | https://conductscience.org/library/papers/23618622 | PubMed |
| 6 | 38847904 | Preoperative consultation for determining the appropriate transfusion strategy. | Blood Res | 2024 | https://conductscience.org/library/papers/38847904 | PubMed |
| 7 | 32439978 | Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells. | Sci Rep | 2020 | https://conductscience.org/library/papers/32439978 | PubMed |
| 8 | 34777386 | Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering. | Front Immunol | 2021 | https://conductscience.org/library/papers/34777386 | PubMed |
| 9 | 36149941 | Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial. | Blood Adv | 2022 | https://conductscience.org/library/papers/36149941 | PubMed |
| 10 | 12920021 | Production of functional platelets by differentiated embryonic stem (ES) cells in vitro. | Blood | 2003 | https://conductscience.org/library/papers/12920021 | PubMed |
| 11 | 30047825 | In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells. | Platelets | 2018 | https://conductscience.org/library/papers/30047825 | PubMed |
| 12 | 10029169 | Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. | Exp Hematol | 1999 | https://conductscience.org/library/papers/10029169 | PubMed |
| 13 | 9446643 | Effects of cytokines on platelet production from blood and marrow CD34+ cells. | Blood | 1998 | https://conductscience.org/library/papers/9446643 | PubMed |
| 14 | 7529062 | Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. | Blood | 1995 | https://conductscience.org/library/papers/7529062 | PubMed |
| 15 | 16420577 | Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. | J Thromb Haemost | 2006 | https://conductscience.org/library/papers/16420577 | PubMed |
| 16 | 26898346 | Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics. | Sci Rep | 2016 | https://conductscience.org/library/papers/26898346 | PubMed |
| 17 | 34360992 | Improving Human Induced Pluripotent Stem Cell-Derived Megakaryocyte Differentiation and Platelet Production. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360992 | PubMed |
| 18 | 16904174 | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. | Cell | 2006 | https://conductscience.org/library/papers/16904174 | PubMed |
| 19 | 32158298 | Platelet Transfusion: And Update on Challenges and Outcomes. | J Blood Med | 2020 | https://conductscience.org/library/papers/32158298 | PubMed |
| 20 | 10863976 | CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells. | Eur J Haematol | 2000 | https://conductscience.org/library/papers/10863976 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42427961 | From Donation to Innovation: New Blood-Derived Products. | Transfus Med Hemother | 2026 | https://conductscience.org/library/papers/42427961 | PubMed |
| 41897498 | Redox Regulation of Megakaryocyte Differentiation and Platelet Biogenesis. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41897498 | PubMed |
| 41463354 | Proteomic Validation of MEG-01-Derived Extracellular Vesicles as Representative Models for Megakaryocyte- and Platelet-Derived Extracellular Vesicles. | Biomolecules | 2025 | https://conductscience.org/library/papers/41463354 | PubMed |
| 40938731 | Induction of moderate DNA damage enhances megakaryopoiesis and platelet production. | Blood Adv | 2026 | https://conductscience.org/library/papers/40938731 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40423909
GET https://conductscience.org/api/papers/v1/40423909/references?page=2